CAH Stock Recent News
CAH LATEST HEADLINES
Initiating Cardinal Health, Inc. with a Buy rating and $239 fair value, driven by specialty distribution growth and successful GMPD turnaround. Specialty segments in autoimmune, urology, and oncology are strategic growth drivers, outpacing traditional pharmaceutical markets and accelerating overall company growth. Recent urology acquisitions and strong specialty focus position Cardinal for above-market growth, despite near-term revenue headwinds from a customer contract expiration.
Cardinal Health, Inc. CAH will release earnings results for the fourth quarter before the opening bell on Tuesday, Aug. 12.
Here, we discuss four stocks from the Dental Supplies industry that are likely to generate wealth for investors amid tariff uncertainty. These are MCK, CAH, WST and COO.
The continued solid uptake of Cardinal Health's products is expected to have driven fiscal fourth-quarter revenues despite an uncertain macroeconomic environment.
Beyond analysts' top-and-bottom-line estimates for Cardinal (CAH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Grant funds will also launch the development of Ohio's first statewide prescription drug repository DUBLIN, Ohio , July 30, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today the expansion of Equity Rx, to help meet the needs of people across Ohio and beyond who cannot afford their prescription medications. Launched as a pilot in Ohio in 2023, Equity Rx was created through a partnership of the Cardinal Health Foundation, the Charitable Healthcare Network (CHN) (an Ohio charitable healthcare organization) and St. Vincent de Paul Charitable Pharmacy in Cincinnati, Ohio.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Div idend stocks ha ve long been a mainstay for investors focused on reliable returns and consistent income.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.